Latest news

Insights

Top 10 Factors That Influence Clinical Trial Protocol Complexity

Executive Summary Clinical trial protocol complexity has become an important consideration in pharmaceutical development. As therapies target increasingly specific patient...
Insights

Risk-Based Monitoring Reimagined: The Next Evolution of Clinical Trial Oversight

   Executive Summary Clinical trial monitoring is shifting from traditional, site-intensive oversight toward more targeted, data-driven approaches. Conventional monitoring models often...
Manufacturing

99% of trial participants receive customised mRNA vaccinations from Merck and Moderna close to the market

Personalizing cancer vaccines is a step closer to market, as Merck and Moderna demonstrated that their mRNA vaccine, combined...
Commercial

AstraZeneca reportedly made a $10 billion deal for the sought-after metabolic jewel Rhythm

Shares of Rhythm Pharmaceuticals jumped 24% after rumors surfaced that AstraZeneca had put in a $10 billion proposal to...
Commercial

Evommune Secures Huge Hinova Deal for Oral Autoimmune Drug

Evommune has struck a licensing agreement with China-based Hinova...
Insights

Top 10 Drug Discovery Platforms to Watch

Executive Summary Artificial intelligence is changing how pharmaceutical companies identify...
Insights

Launch Excellence in the Digital Era

Executive Summary Launching a pharmaceutical product has become increasingly complex. Scientific innovation alone does not guarantee commercial success. Market access...
Insights

Top 10 Factors That Determine the Success of a Drug Candidate

Executive Summary A promising drug candidate must overcome multiple scientific, clinical, regulatory, manufacturing, and commercial challenges before becoming an approved...
Insights

Spatial Biology and Its Commercial Potential

Executive Summary Spatial biology is emerging as an important capability in pharmaceutical research and precision medicine. By examining the location...
Commercial

Novartis Leaves $800M Neuro Partnership, Leaving BioArctic High And Dry

The pharmaceutical industry has lost another potential neuroscience development...
Clinical

Neurocrine Plans Vykat Safety Study After Reports of Patient Deaths

Neurocrine Biosciences plans to conduct a new study in...
Commercial

Just two months after entering the clinic, Sanofi removes the STAT6 degrader from Nurix

Sanofi has decided to end work on a STAT6 degrader from Nurix just two months after taking the inflammatory...
Insights

Top 10 Technologies Improving Patient Retention

Executive Summary Maintaining patient engagement throughout treatment is a growing priority for pharmaceutical companies and healthcare providers. Patients may discontinue...
Insights

Building AI-Ready Data Platforms in Life Sciences

Executive Summary Artificial intelligence is becoming central to pharmaceutical research, clinical development, manufacturing, and commercial operations. Yet many organizations struggle...
Top Industry Leaders 2026 award logo Awards · Nominations open Nominate for the Top Industry Leaders Award 2026 Recognize the senior executives moving pharma, biotech and medtech forward. Self-nominations welcome. Nominate now → Nominations close 15 January 2027

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Vera Health, a clinical artificial intelligence search engine, has secured $28.5 million in Series...
Editorial Team -

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Regulatory

Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense...
Editorial Team -
Insights

Risk-Based Monitoring Reimagined: The Next Evolution of Clinical Trial Oversight

   Executive Summary Clinical trial monitoring is shifting from traditional, site-intensive...
Manufacturing

99% of trial participants receive customised mRNA vaccinations from Merck and Moderna close to the market

Personalizing cancer vaccines is a step closer to market,...
Commercial

AstraZeneca reportedly made a $10 billion deal for the sought-after metabolic jewel Rhythm

Shares of Rhythm Pharmaceuticals jumped 24% after rumors surfaced...
Clinical

Cloudbreak Pharma’s CBT-001 Meets Phase 3 Endpoints in Pterygium Trial

Cloudbreak Pharma has reported statistically significant improvements in both...

Research & Development

Market Access

Manufacturing

Novo Nordisk Sues Eli Lilly Over GLP-1 Drug Advertising Claims

Novo Nordisk has filed a lawsuit against Eli Lilly...
Manufacturing

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Edgewise Therapeutics has reported top-line results from Part D...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Top 10 Factors That Influence Clinical Trial Protocol Complexity

Executive Summary Clinical trial protocol complexity has become an important...
Editorial Team -